Global Preimplantation Genetic Testing 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11241615

Publication Date:

November 28, 2024

Pages:

126

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Preimplantation Genetic Testing market size was valued at US$ 338.6 million in 2023. With growing demand in downstream market, the Preimplantation Genetic Testing is forecast to a readjusted size of US$ 509.6 million by 2030 with a CAGR of 6.0% during review period.
The research report highlights the growth potential of the global Preimplantation Genetic Testing market. Preimplantation Genetic Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Preimplantation Genetic Testing. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Preimplantation Genetic Testing market.
Preimplantation genetic testing is a technique used to identify genetic defects in embryos created through in vitro fertilization (IVF) before pregnancy. Preimplantation genetic diagnosis (PGD) refers specifically to when one or both genetic parents has a known genetic abnormality and testing is performed on an embryo to determine if it also carries a genetic abnormality. In contrast, preimplantation genetic screening (PGS) refers to techniques where embryos from presumed chromosomally normal genetic parents are screened for aneuploidy.
North America accounted for the largest share of the global preimplantation genetic testing market in 2017, followed by Europe. The large share in the North American region is mainly attributed to the rising number of IVF procedures (with decreasing fertility rates), significant adoption of genomic techniques, and the ongoing trend of replacing traditional genomic technologies with advanced and innovative genetic techniques (such as FISH and NGS). The Asia-Pacific region is expected to register the highest growth rate during the forecast period, due to the growing focus of players on emerging markets and improvements in healthcare infrastructure in these regions.
Key Features:
The report on Preimplantation Genetic Testing market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Preimplantation Genetic Testing market. It may include historical data, market segmentation by Type (e.g., Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Preimplantation Genetic Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Preimplantation Genetic Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Preimplantation Genetic Testing industry. This include advancements in Preimplantation Genetic Testing technology, Preimplantation Genetic Testing new entrants, Preimplantation Genetic Testing new investment, and other innovations that are shaping the future of Preimplantation Genetic Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Preimplantation Genetic Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Preimplantation Genetic Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Preimplantation Genetic Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Preimplantation Genetic Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Preimplantation Genetic Testing market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Preimplantation Genetic Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Preimplantation Genetic Testing market.
麻豆原创 Segmentation:
Preimplantation Genetic Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
Segmentation by application
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher
Agilent Technologies
Perkinelmer
Coopersurgical
Abbott Laboratories
Natera
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Beijing Genomics Institute
Good Start Genetics
Invicta Genetics
Combimatrix
Genea Limited
Progenesis

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Preimplantation Genetic Testing 麻豆原创 Size 2019-2030
2.1.2 Preimplantation Genetic Testing 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Preimplantation Genetic Testing Segment by Type
2.2.1 Preimplantation Genetic Screening
2.2.2 Preimplantation Genetic Diagnosis
2.3 Preimplantation Genetic Testing 麻豆原创 Size by Type
2.3.1 Preimplantation Genetic Testing 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Preimplantation Genetic Testing 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Preimplantation Genetic Testing Segment by Application
2.4.1 Maternity Centers & Fertility Clinics
2.4.2 Hospitals, Diagnostic Labs, and Service Providers
2.4.3 Research Laboratories & Academic Institutes
2.5 Preimplantation Genetic Testing 麻豆原创 Size by Application
2.5.1 Preimplantation Genetic Testing 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Preimplantation Genetic Testing 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Preimplantation Genetic Testing 麻豆原创 Size by Player
3.1 Preimplantation Genetic Testing 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Preimplantation Genetic Testing Revenue by Players (2019-2024)
3.1.2 Global Preimplantation Genetic Testing Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Preimplantation Genetic Testing Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Preimplantation Genetic Testing by Regions
4.1 Preimplantation Genetic Testing 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Preimplantation Genetic Testing 麻豆原创 Size Growth (2019-2024)
4.3 APAC Preimplantation Genetic Testing 麻豆原创 Size Growth (2019-2024)
4.4 Europe Preimplantation Genetic Testing 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Preimplantation Genetic Testing 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Preimplantation Genetic Testing 麻豆原创 Size by Country (2019-2024)
5.2 Americas Preimplantation Genetic Testing 麻豆原创 Size by Type (2019-2024)
5.3 Americas Preimplantation Genetic Testing 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preimplantation Genetic Testing 麻豆原创 Size by Region (2019-2024)
6.2 APAC Preimplantation Genetic Testing 麻豆原创 Size by Type (2019-2024)
6.3 APAC Preimplantation Genetic Testing 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Preimplantation Genetic Testing by Country (2019-2024)
7.2 Europe Preimplantation Genetic Testing 麻豆原创 Size by Type (2019-2024)
7.3 Europe Preimplantation Genetic Testing 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Preimplantation Genetic Testing by Region (2019-2024)
8.2 Middle East & Africa Preimplantation Genetic Testing 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Preimplantation Genetic Testing 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Preimplantation Genetic Testing 麻豆原创 Forecast
10.1 Global Preimplantation Genetic Testing Forecast by Regions (2025-2030)
10.1.1 Global Preimplantation Genetic Testing Forecast by Regions (2025-2030)
10.1.2 Americas Preimplantation Genetic Testing Forecast
10.1.3 APAC Preimplantation Genetic Testing Forecast
10.1.4 Europe Preimplantation Genetic Testing Forecast
10.1.5 Middle East & Africa Preimplantation Genetic Testing Forecast
10.2 Americas Preimplantation Genetic Testing Forecast by Country (2025-2030)
10.2.1 United States Preimplantation Genetic Testing 麻豆原创 Forecast
10.2.2 Canada Preimplantation Genetic Testing 麻豆原创 Forecast
10.2.3 Mexico Preimplantation Genetic Testing 麻豆原创 Forecast
10.2.4 Brazil Preimplantation Genetic Testing 麻豆原创 Forecast
10.3 APAC Preimplantation Genetic Testing Forecast by Region (2025-2030)
10.3.1 China Preimplantation Genetic Testing 麻豆原创 Forecast
10.3.2 Japan Preimplantation Genetic Testing 麻豆原创 Forecast
10.3.3 Korea Preimplantation Genetic Testing 麻豆原创 Forecast
10.3.4 Southeast Asia Preimplantation Genetic Testing 麻豆原创 Forecast
10.3.5 India Preimplantation Genetic Testing 麻豆原创 Forecast
10.3.6 Australia Preimplantation Genetic Testing 麻豆原创 Forecast
10.4 Europe Preimplantation Genetic Testing Forecast by Country (2025-2030)
10.4.1 Germany Preimplantation Genetic Testing 麻豆原创 Forecast
10.4.2 France Preimplantation Genetic Testing 麻豆原创 Forecast
10.4.3 UK Preimplantation Genetic Testing 麻豆原创 Forecast
10.4.4 Italy Preimplantation Genetic Testing 麻豆原创 Forecast
10.4.5 Russia Preimplantation Genetic Testing 麻豆原创 Forecast
10.5 Middle East & Africa Preimplantation Genetic Testing Forecast by Region (2025-2030)
10.5.1 Egypt Preimplantation Genetic Testing 麻豆原创 Forecast
10.5.2 South Africa Preimplantation Genetic Testing 麻豆原创 Forecast
10.5.3 Israel Preimplantation Genetic Testing 麻豆原创 Forecast
10.5.4 Turkey Preimplantation Genetic Testing 麻豆原创 Forecast
10.5.5 GCC Countries Preimplantation Genetic Testing 麻豆原创 Forecast
10.6 Global Preimplantation Genetic Testing Forecast by Type (2025-2030)
10.7 Global Preimplantation Genetic Testing Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina Preimplantation Genetic Testing Product Offered
11.1.3 Illumina Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Information
11.2.2 Thermo Fisher Preimplantation Genetic Testing Product Offered
11.2.3 Thermo Fisher Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Thermo Fisher Main Business Overview
11.2.5 Thermo Fisher Latest Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Information
11.3.2 Agilent Technologies Preimplantation Genetic Testing Product Offered
11.3.3 Agilent Technologies Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Agilent Technologies Main Business Overview
11.3.5 Agilent Technologies Latest Developments
11.4 Perkinelmer
11.4.1 Perkinelmer Company Information
11.4.2 Perkinelmer Preimplantation Genetic Testing Product Offered
11.4.3 Perkinelmer Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Perkinelmer Main Business Overview
11.4.5 Perkinelmer Latest Developments
11.5 Coopersurgical
11.5.1 Coopersurgical Company Information
11.5.2 Coopersurgical Preimplantation Genetic Testing Product Offered
11.5.3 Coopersurgical Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Coopersurgical Main Business Overview
11.5.5 Coopersurgical Latest Developments
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Information
11.6.2 Abbott Laboratories Preimplantation Genetic Testing Product Offered
11.6.3 Abbott Laboratories Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Abbott Laboratories Main Business Overview
11.6.5 Abbott Laboratories Latest Developments
11.7 Natera
11.7.1 Natera Company Information
11.7.2 Natera Preimplantation Genetic Testing Product Offered
11.7.3 Natera Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Natera Main Business Overview
11.7.5 Natera Latest Developments
11.8 Rubicon Genomics
11.8.1 Rubicon Genomics Company Information
11.8.2 Rubicon Genomics Preimplantation Genetic Testing Product Offered
11.8.3 Rubicon Genomics Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Rubicon Genomics Main Business Overview
11.8.5 Rubicon Genomics Latest Developments
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Information
11.9.2 Oxford Gene Technology Preimplantation Genetic Testing Product Offered
11.9.3 Oxford Gene Technology Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Oxford Gene Technology Main Business Overview
11.9.5 Oxford Gene Technology Latest Developments
11.10 Yikon Genomics
11.10.1 Yikon Genomics Company Information
11.10.2 Yikon Genomics Preimplantation Genetic Testing Product Offered
11.10.3 Yikon Genomics Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Yikon Genomics Main Business Overview
11.10.5 Yikon Genomics Latest Developments
11.11 Scigene
11.11.1 Scigene Company Information
11.11.2 Scigene Preimplantation Genetic Testing Product Offered
11.11.3 Scigene Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Scigene Main Business Overview
11.11.5 Scigene Latest Developments
11.12 Beijing Genomics Institute
11.12.1 Beijing Genomics Institute Company Information
11.12.2 Beijing Genomics Institute Preimplantation Genetic Testing Product Offered
11.12.3 Beijing Genomics Institute Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Beijing Genomics Institute Main Business Overview
11.12.5 Beijing Genomics Institute Latest Developments
11.13 Good Start Genetics
11.13.1 Good Start Genetics Company Information
11.13.2 Good Start Genetics Preimplantation Genetic Testing Product Offered
11.13.3 Good Start Genetics Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Good Start Genetics Main Business Overview
11.13.5 Good Start Genetics Latest Developments
11.14 Invicta Genetics
11.14.1 Invicta Genetics Company Information
11.14.2 Invicta Genetics Preimplantation Genetic Testing Product Offered
11.14.3 Invicta Genetics Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Invicta Genetics Main Business Overview
11.14.5 Invicta Genetics Latest Developments
11.15 Combimatrix
11.15.1 Combimatrix Company Information
11.15.2 Combimatrix Preimplantation Genetic Testing Product Offered
11.15.3 Combimatrix Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 Combimatrix Main Business Overview
11.15.5 Combimatrix Latest Developments
11.16 Genea Limited
11.16.1 Genea Limited Company Information
11.16.2 Genea Limited Preimplantation Genetic Testing Product Offered
11.16.3 Genea Limited Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 Genea Limited Main Business Overview
11.16.5 Genea Limited Latest Developments
11.17 Progenesis
11.17.1 Progenesis Company Information
11.17.2 Progenesis Preimplantation Genetic Testing Product Offered
11.17.3 Progenesis Preimplantation Genetic Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 Progenesis Main Business Overview
11.17.5 Progenesis Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.